BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 9657371)

  • 1. Detection of human chorionic gonadotrophin misuse in sports.
    Delbeke FT; Van Eenoo P; De Backer P
    Int J Sports Med; 1998 May; 19(4):287-90. PubMed ID: 9657371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analytic evaluation of the beta-human chorionic gonadotropin assay on the Abbott IMx and Elecsys2010 for its use in doping control.
    Shahzad K; Kim DH; Kang MJ
    Clin Biochem; 2007 Nov; 40(16-17):1259-65. PubMed ID: 17884034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of two immunoassays for the measurement of human chorionic gonadotropin in urine for anti-doping purposes.
    Robinson N; Sottas PE; Saugy M
    Clin Lab; 2010; 56(5-6):197-206. PubMed ID: 20575467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitation of whole molecule human chorionic gonadotropin and free beta-human chorionic gonadotropin subunit in the Abbott IMx analyser.
    Figard SD; Bodner JB; Babik DM; Mlyniec DM; Simpson B; Venetucci M; Ogunro EA
    Eur J Clin Chem Clin Biochem; 1991 Jan; 29(1):77-80. PubMed ID: 1710936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Doping control of testosterone and human chorionic gonadotrophin: a case study.
    de Boer D; de Jong EG; van Rossum JM; Maes RA
    Int J Sports Med; 1991 Feb; 12(1):46-51. PubMed ID: 2030059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urine free beta hCG and beta core in pregnancies affected by Down's syndrome.
    Spencer K; Aitken DA; Macri JN; Buchanan PD
    Prenat Diagn; 1996 Jul; 16(7):605-13. PubMed ID: 8843469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring human chorionic gonadotrophin level: evaluation of urine as an alternative specimen type.
    Chen YN; Deng MD; Zeng LJ; Wu MY
    Br J Biomed Sci; 1999; 56(3):199-203. PubMed ID: 10824329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The correlation of beta-subunit human chorionic gonadotropin level in the serum and first morning urine of patients with gestational trophoblastic disease.
    Benjapibal M; Wataganara T; Senawong S; Boriboonhirunsarn D; Suphanit I
    J Med Assoc Thai; 2001 Jul; 84(7):1000-5. PubMed ID: 11759958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New decision limits and quality-control material for detecting human chorionic gonadotropin misuse in sports.
    Laidler P; Cowan DA; Hider RC; Kicman AT
    Clin Chem; 1994 Jul; 40(7 Pt 1):1306-11. PubMed ID: 8013104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maternal serum free-beta-chorionic gonadotrophin, pregnancy-associated plasma protein-A and fetal nuchal translucency thickness at 10-13(+6) weeks in relation to co-variables in pregnant Saudi women.
    Ardawi MS; Nasrat HA; Rouzi AA; Qari MH; Al-Qahtani MH; Abuzenadah AM
    Prenat Diagn; 2007 Apr; 27(4):303-11. PubMed ID: 17269128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gestational trophoblastic diseases: 3. Human chorionic gonadotropin-free beta-subunit, a reliable marker of placental site trophoblastic tumors.
    Cole LA; Khanlian SA; Muller CY; Giddings A; Kohorn E; Berkowitz R
    Gynecol Oncol; 2006 Aug; 102(2):160-4. PubMed ID: 16631918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endometrial adenocarcinoma associated with elevated serum concentrations of the free beta subunit of human chorionic gonadotropin.
    Grenache DG; Moller KA; Groben PM
    Am J Clin Pathol; 2004 May; 121(5):748-53. PubMed ID: 15151215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of hCG in trophoblastic disease. The USA hCG reference service experience.
    Cole LA; Butler S
    J Reprod Med; 2002 Jun; 47(6):433-44. PubMed ID: 12092011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the beta-Neocept test for early pregnancy.
    Yuen BH; Pride SM; Callegari PB
    Can Med Assoc J; 1984 Sep; 131(6):583-5. PubMed ID: 6206935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary human chorionic gonadotropin free beta-subunit and beta-core fragment: a new marker of gynecological cancers.
    Cole LA; Wang YX; Elliott M; Latif M; Chambers JT; Chambers SK; Schwartz PE
    Cancer Res; 1988 Mar; 48(5):1356-60. PubMed ID: 3342414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the Abbott IMx assay system for the measurement of human chorionic gonadotropin levels in the treatment of ectopic pregnancy.
    Goodman DB; Bulley M; Hendricks M; Senior M
    Arch Pathol Lab Med; 1993 Jul; 117(7):701-3. PubMed ID: 8323432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First-trimester screening for trisomy 21 by free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A: impact of maternal and pregnancy characteristics.
    Kagan KO; Wright D; Spencer K; Molina FS; Nicolaides KH
    Ultrasound Obstet Gynecol; 2008 May; 31(5):493-502. PubMed ID: 18432600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ectopic production of beta-subunit of human chorionic gonadotropin in malignant lymphoma.
    Senba M; Watanabe M
    Zentralbl Pathol; 1991; 137(5):402-4. PubMed ID: 1724916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The free beta-subunit of human chorionic gonadotropin as a prognostic factor in renal cell carcinoma.
    Hotakainen K; Ljungberg B; Paju A; Rasmuson T; Alfthan H; Stenman UH
    Br J Cancer; 2002 Jan; 86(2):185-9. PubMed ID: 11870503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunocytochemical evaluation of human prostatic carcinomas for carcinoembryonic antigen, nonspecific cross-reacting antigen, beta-chorionic gonadotrophin, and prostate-specific antigen.
    Purnell DM; Heatfield BM; Trump BF
    Cancer Res; 1984 Jan; 44(1):285-92. PubMed ID: 6197163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.